Clinical Trial Update: Investigation of Impact of Indocyanine Green on Volume of Lymphadenectomy in Resectable Gastric Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating whether Indocyanine Green imaging affects the volume of lymphadenectomy during resection of resectable gastric cancer; curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Indocyanine Green (Indocyanine Green)

Snippet

Sponsor: Ukrainian Society of Clinical Oncology | Conditions: Gastric Cancer Stage II, Gastric Cancer Stage III | Phase 3 | Status: RECRUITING